Age, Rhythm, and Low-Flow Duration Predict Neurological Recovery After ECPR

The Triage Dilemma in Refractory Cardiac Arrest

Extracorporeal cardiopulmonary resuscitation (ECPR) has become a critical intervention for patients experiencing refractory cardiac arrest, offering a survival advantage over conventional resuscitation methods [1, 2]. However, this highly invasive and resource-intensive procedure carries substantial risks, including a high incidence of hypoxic-ischemic brain injury [3]. Consequently, international resuscitation systems struggle with immense variability in patient selection, relying on inconsistent age cut-offs and rhythm criteria to determine eligibility [4]. The core clinical challenge lies in identifying which patients are most likely to achieve meaningful neurological recovery rather than merely surviving with severe cognitive deficits [5]. A recent cohort study now offers specific predictive data to help clinicians refine their triage criteria and optimize long-term neurological outcomes.

Quantifying Six-Month Neurological Recovery Rates

To quantify the real-world outcomes of extracorporeal life support, researchers evaluated 295 consecutive patients who received extracorporeal cardiopulmonary resuscitation for refractory cardiac arrest. The investigators stratified this cohort based on the location of the initial event, analyzing 117 individuals with in-hospital cardiac arrest (IHCA) and 178 individuals with out-of-hospital cardiac arrest (OHCA). The primary metric for clinical success was a favorable neurological outcome at six months, defined as a Cerebral Performance Category (CPC) score of 1 to 2 (a standardized scale indicating mild or no neurological disability). Across the entire study population, 17.3% of the total patient cohort achieved a favorable neurological outcome at the six-month mark.

When analyzing the results by the location of the arrest, the data revealed a stark contrast in recovery trajectories. Favorable neurological outcomes (CPC 1-2) were significantly higher in the IHCA group compared to the OHCA group (28.2% versus 10.1%; p<0.0001). This discrepancy underscores the critical impact of immediate response times and controlled clinical environments on brain preservation. Furthermore, the findings highlight the profound risks associated with aggressive resuscitation efforts. At six months, 4.4% of the total patient cohort survived with severe long-term neurological sequelae, defined as a CPC score of 3 to 4 (a classification denoting severe disability or a vegetative state). For practicing physicians, these numbers emphasize the high clinical stakes involved in deploying such invasive life support, reinforcing the need for precise patient selection to minimize the burden of profound neurological morbidity.

Three Independent Predictors of Favorable Outcomes

To assist clinicians during high-stakes emergency triage, the researchers identified three specific clinical variables that independently predicted a favorable neurological recovery. First, the analysis demonstrated that younger age was an independent predictor of achieving a CPC score of 1 to 2 (odds ratio [OR] 0.95 per year, 95% CI 0.92-0.98). For practicing physicians, this indicates that the probability of a good neurological recovery decreases by five percent for every additional year of patient age. This provides a concrete metric when evaluating older patients for extracorporeal life support, helping teams weigh the likelihood of meaningful survival against the risks of severe brain injury.

Beyond patient age, the cardiac electrical presentation at the time of arrest played a critical prognostic role. An initial shockable rhythm was an independent predictor of achieving a CPC score of 1 to 2 (adjusted odds ratio [aOR] 2.7; 95% CI 1.11-7.04). Patients presenting with ventricular fibrillation or pulseless ventricular tachycardia were nearly three times more likely to survive with intact neurological function compared to those with non-shockable rhythms. Finally, the speed of the resuscitation effort heavily influenced brain preservation. The researchers found that a shorter low-flow duration (the time elapsed from the initiation of cardiopulmonary resuscitation to the establishment of extracorporeal circulation) was an independent predictor of achieving a CPC score of 1 to 2 (OR 0.95 per minute increase, 95% CI 0.93-0.97). This metric carries a steep penalty, as the data show a five percent reduction in the odds of a favorable neurological outcome for every single minute of delay. This finding underscores the absolute necessity of rapid deployment protocols in emergency departments and intensive care units.

Balancing Selection Criteria and Patient Characterization

To translate these individual predictors into a practical triage tool, the researchers evaluated the clinical impact of combining them. They found that applying stepwise selection based on age, initial rhythm, and low-flow duration progressively increased the proportion of survivors with favorable outcomes. By strictly filtering candidates through these three variables, clinicians can concentrate highly resource-intensive extracorporeal life support on the individuals most likely to achieve meaningful neurological recovery. However, this stringent filtering introduces a difficult ethical and clinical trade-off. The data showed that applying stepwise selection based on these criteria also excluded a small proportion of patients who might have recovered. For practicing physicians, this highlights the inherent tension in emergency triage. Maximizing the overall success rate of a program inevitably risks denying potentially life-saving therapy to a minority of atypical patients who could have defied the statistical odds.

Despite the risk of excluding a few viable candidates, the authors conclude that establishing pre-treatment selection criteria is essential to optimize the use of extracorporeal cardiopulmonary resuscitation and enhance long-term neurological outcomes. Without standardized guidelines, hospitals risk deploying invasive perfusion technologies on patients with an overwhelmingly high probability of severe brain injury or death. To refine this selection process further and minimize the inappropriate exclusion of viable candidates, the researchers looked beyond isolated variables. Exploratory phenotype-based analyses suggest that multidimensional patient characterization may complement traditional selection criteria. By evaluating broader clinical phenotypes (a comprehensive profile of a patient's observable traits, comorbidities, and physiological state) rather than relying solely on rigid cut-offs for age or time, clinicians may eventually develop more nuanced triage protocols. This multidimensional approach could help emergency teams better identify which patients will truly benefit from extracorporeal resuscitation, ultimately improving survival while protecting neurological function.

References

1. Escareño MDLAL, Dueñas CAF, Gómez FJB, et al. Extracorporeal versus Conventional Cardiopulmonary Resuscitation in Refractory Cardiac Arrest: Systematic Review of Survival and Neurological Outcomes. Salud, Ciencia y Tecnología. 2026. doi:10.56294/saludcyt20262508

2. Low CJW, Ling RR, Ramanathan K, et al. Extracorporeal cardiopulmonary resuscitation versus conventional CPR in cardiac arrest: an updated meta-analysis and trial sequential analysis. Critical Care. 2024. doi:10.1186/s13054-024-04830-5

3. Migdady I, Rice C, Deshpande A, et al. Brain Injury and Neurologic Outcome in Patients Undergoing Extracorporeal Cardiopulmonary Resuscitation: A Systematic Review and Meta-Analysis.. Critical care medicine. 2020. doi:10.1097/CCM.0000000000004377

4. Alenazi A, Aljanoubi M, Yeung J, Madan J, Johnson S, Couper K. Variability in patient selection criteria across extracorporeal cardiopulmonary resuscitation (ECPR) systems: A systematic review.. Resuscitation. 2024. doi:10.1016/j.resuscitation.2024.110403

5. Redfors B, Špaček R, Henningsson A, et al. The Pre-ECPR score for predicting favorable neurological outcomes after extracorporeal cardiopulmonary resuscitation: protocol for external validation in the Prague OHCA trial cohort.. Resuscitation plus. 2026. doi:10.1016/j.resplu.2025.101213